Related Experiment Video
Updated: Sep 7, 2025

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate
Simone Fabbian1, Gabriele Giachin1, Massimo Bellanda1,2
1Department of Chemical Sciences, University of Padova, Padova, Italy.
Abstract:
CK2 is a Ser/Thr protein kinase involved in many cellular processes such as gene expression, cell cycle progression, cell growth and differentiation, embryogenesis, and apoptosis. Aberrantly high CK2 activity is widely documented in cancer, but the enzyme is also involved in several other pathologies, such as diabetes, inflammation, neurodegeneration, and viral infections, including COVID-19. Over the last years, a large number of small-molecules able to inhibit the CK2 activity have been reported, mostly acting with an ATP-competitive mechanism. Polyoxometalates (POMs), are metal-oxide polyanionic clusters of various structures and dimensions, with unique chemical and physical properties. POMs were identified as nanomolar CK2 inhibitors, but their mechanism of inhibition and CK2 binding site remained elusive. Here, we present the biochemical and biophysical characterizing of the interaction of CK2α with a ruthenium-based polyoxometalate, [Ru4(μ-OH)2(μ-O)4(H2O)4 (γ-SiW10O36)2]10- (Ru4POM), a potent inhibitor of CK2. Using analytical Size-Exclusion Chromatography (SEC), Isothermal Titration Calorimetry (ITC), and SAXS we were able to unravel the mechanism of inhibition of Ru4POM. Ru4POM binds to the positively-charged substrate binding region of the enzyme through electrostatic interactions, triggering the dimerization of the enzyme which consequently is inactivated. Ru4POM is the first non-peptide molecule showing a substrate-competitive mechanism of inhibition for CK2. On the basis of SAXS data, a structural model of the inactivated (CK2α)2(Ru4POM)2 complex is presented.
Insights
A novel ruthenium-based polyoxometalate (Ru4POM) inhibits the protein kinase CK2 by binding to its substrate region, causing enzyme dimerization and inactivation. This discovery reveals a new substrate-competitive inhibition mechanism for CK2, offering potential therapeutic strategies.
Area of Science:
- Biochemistry
- Structural Biology
- Chemical Biology
Background:
- Casein kinase 2 (CK2) is a crucial Ser/Thr protein kinase implicated in numerous cellular functions and various pathologies, including cancer, diabetes, and viral infections.
- While many CK2 inhibitors exist, their mechanisms of action, particularly for non-peptide inhibitors like polyoxometalates (POMs), remain largely uncharacterized.
Purpose of the Study:
- To elucidate the biochemical and biophysical mechanism by which a ruthenium-based polyoxometalate (Ru4POM) inhibits the CK2α enzyme.
- To characterize the binding site and interaction mode of Ru4POM with CK2α.
- To present a structural model of the inhibited CK2α complex.
Main Methods:
- Biochemical and biophysical characterization techniques including analytical Size-Exclusion Chromatography (SEC), Isothermal Titration Calorimetry (ITC), and Small-Angle X-ray Scattering (SAXS).
Main Results:
- Ru4POM potently inhibits CK2α through a substrate-competitive mechanism, a first for non-peptide molecules.
- Electrostatic interactions mediate Ru4POM binding to the positively charged substrate binding region of CK2α.
- Ru4POM binding induces CK2α dimerization, leading to enzyme inactivation, with a structural model of the (CK2α)2(Ru4POM)2 complex elucidated via SAXS.
Conclusions:
- Ru4POM represents a novel class of CK2 inhibitors with a unique substrate-competitive mechanism.
- The findings provide critical insights into CK2 inhibition and offer a foundation for developing new therapeutic agents targeting CK2-related diseases.
More Related Videos
Related Concept Videos
Olefin Metathesis Polymerization: Overview
Ruthenium-based Grubbs catalyst is the most commonly used catalyst for olefin metathesis polymerization. Grubbs catalyst consists...
Inhibition of Cdk Activity
Introduction to Mechanisms of Enzyme Catalysis
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Olefin Metathesis Polymerization: Ring-Opening Metathesis Polymerization (ROMP)
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...

